MicroRNA: A signature for cancer progression
- PMID: 33770669
- DOI: 10.1016/j.biopha.2021.111528
MicroRNA: A signature for cancer progression
Abstract
MicroRNAs (miRNAs) are a group of small non-coding RNAs that post-transcriptionally control expression of genes by targeting mRNAs. miRNA alterations partake in the establishment and progression of different types of human cancer. Consequently, expression profiling of miRNA in human cancers has correlations with cancer detection, staging, progression, and response to therapies. Particularly, amplification, deletion, abnormal pattern of epigenetic factors and the transcriptional factors that mediate regulation of primary miRNA frequently change the landscape of miRNA expression in cancer. Indeed, changes in the quantity and quality of miRNAs are associated with the initiation of cancer, its progression and metastasis. Additionally, miRNA profiling has been used to categorize genes that can affect oncogenic pathways in cancer. Here, we discuss several circulating miRNA signatures, their expression profiles in different types of cancer and their impacts on cellular processes.
Keywords: Cancer; Expression; MiRNA.
Copyright © 2021 The Authors. Published by Elsevier Masson SAS.. All rights reserved.
Similar articles
-
Regulatory Mechanism of MicroRNA Expression in Cancer.Int J Mol Sci. 2020 Mar 3;21(5):1723. doi: 10.3390/ijms21051723. Int J Mol Sci. 2020. PMID: 32138313 Free PMC article. Review.
-
Disruption of microRNA nuclear transport in human cancer.Semin Cancer Biol. 2014 Aug;27:46-51. doi: 10.1016/j.semcancer.2014.02.012. Epub 2014 Mar 7. Semin Cancer Biol. 2014. PMID: 24607282 Review.
-
MicroRNA expression and gene regulation drive breast cancer progression and metastasis in PyMT mice.Breast Cancer Res. 2016 Jul 22;18(1):75. doi: 10.1186/s13058-016-0735-z. Breast Cancer Res. 2016. PMID: 27449149 Free PMC article.
-
MicroRNA signatures in human cancers.Nat Rev Cancer. 2006 Nov;6(11):857-66. doi: 10.1038/nrc1997. Nat Rev Cancer. 2006. PMID: 17060945 Review.
-
Levels of MicroRNA Heterogeneity in Cancer Biology.Mol Diagn Ther. 2017 Oct;21(5):511-523. doi: 10.1007/s40291-017-0285-9. Mol Diagn Ther. 2017. PMID: 28620889 Review.
Cited by
-
Unveiling caspase-2 regulation by non-coding RNAs.Cell Death Dis. 2022 Sep 28;13(9):834. doi: 10.1038/s41419-022-05270-1. Cell Death Dis. 2022. PMID: 36171196 Free PMC article. Review.
-
Identification of microRNA editing sites in clear cell renal cell carcinoma.Sci Rep. 2023 Sep 13;13(1):15117. doi: 10.1038/s41598-023-42302-y. Sci Rep. 2023. PMID: 37704698 Free PMC article.
-
Diagnostic value of exosomal noncoding RNA in lung cancer: a meta-analysis.Front Oncol. 2024 Apr 17;14:1357248. doi: 10.3389/fonc.2024.1357248. eCollection 2024. Front Oncol. 2024. PMID: 38694786 Free PMC article.
-
An Insight into the Arising Role of MicroRNAs in Hepatocellular Carcinoma: Future Diagnostic and Therapeutic Approaches.Int J Mol Sci. 2023 Apr 12;24(8):7168. doi: 10.3390/ijms24087168. Int J Mol Sci. 2023. PMID: 37108330 Free PMC article. Review.
-
Epigenetic modulation of ferroptosis in cancer: Identifying epigenetic targets for novel anticancer therapy.Cell Oncol (Dordr). 2023 Dec;46(6):1605-1623. doi: 10.1007/s13402-023-00840-7. Epub 2023 Jul 12. Cell Oncol (Dordr). 2023. PMID: 37438601 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical